small molecule

VESANOID

TRETINOIN

Loss of exclusivity—loss of exclusivity
CompanyCHEPLAPHARM ARZNEIMITTEL GMBH

Drug detail

Brand nameVESANOID
Active ingredientTRETINOIN
Strength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 1995
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.